The Gross Margin of Interpace Biosciences Inc (IDXG) is 59.44%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 59.44% |
| 2022-12-31 | 57.23% |
| 2021-12-31 | 56.80% |
| 2020-12-31 | 33.02% |
| 2019-12-31 | 34.30% |
| 2018-12-31 | 53.42% |
| 2017-12-31 | 53.46% |
| 2016-12-31 | 48.85% |
| 2015-12-31 | 26.60% |
| 2014-12-31 | 13.33% |